Evidence map›Paper›PMID 40615578›Full record

ReviewEMBO reports2025

Molecular mechanisms of co-infections.

Philipp Darius Konstantin Walch, Petr Broz

Abstract readReview
In one paragraph

Review in EMBO reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Philipp Darius Konstantin WalchDepartment of Immunobiology, University of Lausanne, Chemin des Boveresses 155, CH-1066, Epalinges, Switzerland. philipp.walch@unil.ch.ORCID 0000-0002-7978-5685
Petr BrozDepartment of Immunobiology, University of Lausanne, Chemin des Boveresses 155, CH-1066, Epalinges, Switzerland. petr.broz@unil.ch.ORCID 0000-0002-2334-7790

Funding

Swiss National Science Foundation 310030_192523Swiss National Science Foundation TMPFP3_217085
6 · The paper itself

Abstract

Co-infections generally cause exacerbated pathologies in patients, yet a knowledge gap between clinical data and the underlying molecular mechanisms remains. Clinical studies focus on patient outcome, but much less is known about molecular mechanisms and convergence points that define the interaction between different pathogens. In this review, we will summarize the current standing of the literature at the various scales of magnitude that co-infections impact: epidemiology, clinical observations, tissue- and organ-specificity, the single-cell level, and molecular mechanisms. Given the scarcity of systematic research across systems, we will focus on molecular interaction points that have been identified, comment on their generalizability and, where required, extrapolate from single-pathogen studies. More research of the host-pathogen-pathogen interface is direly warranted, and we hope to inspire advances addressing the intricate network between two co-occurring pathogens and their host. In addition to direct implications for co-infections, acquiring a better understanding of how microorganisms interact in this complex environment will enable us to better understand single-pathogen infections as well, which can lead to the development of novel treatment approaches.

Indexed as

CoinfectionHost-Pathogen InteractionsAnimalsHumansCo-infectionHost–pathogen InteractionsImmune ResponseSystems Biology

Identifiers

PMID40615578
PMCPMC12332146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.